LINEAGE THERAPEUTICS Trademark

Trademark Overview

On Friday, March 29, 2013, a trademark application was filed for LINEAGE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LINEAGE THERAPEUTICS trademark a serial number of 85890350. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 11, 2024. This trademark is owned by Amedra Pharmaceuticals LLC. The LINEAGE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, anthelmintics, antibacterials, antidepressants, anti-infectives, anti-malarial agents, hematologic and oncologic agents; pharmaceutical preparations for the treatment of anaphylaxis, metabolic disorders, inflammatory disorders, autoimmune disorders, diseases of the central nervous system, diseases of the cardiovascular system, and diseases of the respiratory system
lineage therapeutics

General Information

Serial Number85890350
Word MarkLINEAGE THERAPEUTICS
Filing DateFriday, March 29, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 11, 2024
Registration Number4503141
Registration DateTuesday, March 25, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, anthelmintics, antibacterials, antidepressants, anti-infectives, anti-malarial agents, hematologic and oncologic agents; pharmaceutical preparations for the treatment of anaphylaxis, metabolic disorders, inflammatory disorders, autoimmune disorders, diseases of the central nervous system, diseases of the cardiovascular system, and diseases of the respiratory system
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2024
Primary Code005
First Use Anywhere DateTuesday, November 13, 2012
First Use In Commerce DateMonday, June 10, 2013

Trademark Owner History

Party NameIMPAX LABORATORIES, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBRIDGEWATER, NJ 08807
Party NameLINEAGE THERAPEUTICS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressHORSHAM, PA 190447707
Party NameAmedra Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHorsham, PA 19044
Party NameAmedra Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHorsham, PA 19044
Party NameAmedra Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHorsham, PA 19044

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2013NEW APPLICATION ENTERED
Thursday, April 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 11, 2013ASSIGNED TO EXAMINER
Friday, July 12, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, July 12, 2013EXAMINERS AMENDMENT E-MAILED
Friday, July 12, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 12, 2013EXAMINER'S AMENDMENT ENTERED
Friday, July 12, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 29, 2013ASSIGNED TO LIE
Thursday, August 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 14, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2013PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 16, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, January 16, 2014USE AMENDMENT FILED
Monday, February 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 20, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 20, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 20, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, February 21, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, March 26, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 18, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 15, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 8, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 25, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 25, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 2, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 2, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 2, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 1, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, March 25, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, October 11, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, January 29, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

therapeutics lineage diseases disorders system pharmaceutical agents anti preparations respiratory inflammatory autoimmune